| Literature DB >> 29081002 |
Anri Kuroda1, Takahiro Fuchigami1, Satoshi Fuke1, Natsu Koyama1, Kazuhiro Ikenaka2,3, Seiji Hitoshi4,5,6.
Abstract
Minocycline not only has antibacterial action but also produces a variety of pharmacological effects. It has drawn considerable attention as a therapeutic agent for symptoms caused by inflammation in many neurological disorders, leading to several clinical trials. Although some of these effects are mediated through its function of suppressing microglial activation, it is not clear whether minocycline acts on other cell types in the adult brain. In this study, we utilized a colony-forming neurosphere assay, in which neural stem cells (NSCs) clonally proliferate to form floating colonies, called neurospheres. We found that minocycline (at therapeutically relevant concentrations in cerebrospinal fluid) enhances the self-renewal capability of NSCs derived from the subependymal zone of adult mouse brain and facilitates their differentiation into oligodendrocytes. Importantly, these effects were independent of a suppression of microglial activation and were specifically observed with minocycline (among tetracycline derivatives). In addition, the size of the NSC population in the adult brain was increased when minocycline was infused into the lateral ventricle by an osmotic minipump in vivo. While precise molecular mechanisms of how minocycline alters the behavior of adult NSCs remain unknown, our data provide a basis for the clinical use of minocycline to treat neurodegenerative and demyelinating diseases.Entities:
Keywords: Microglia; Neural stem cell; Oligodendrocyte; Self-renewal
Mesh:
Substances:
Year: 2017 PMID: 29081002 DOI: 10.1007/s11064-017-2422-6
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996